Rheumatoid Arthritis Clinical Trial
Official title:
Evaluation of Non-surgical Periodontal Therapy in Patients With Rheumatoid Arthritis
Some clinical and epidemiological studies have revealed a high prevalence of periodontitis and tooth loss in patients with rheumatoid arthritis. The aim of this study was to evaluate the efficacy of periodontal scaling and oral hygiene instruction for patients with mild chronic periodontitis and rheumatoid arthritis through clinical periodontal parameters and laboratory tests for CRP (C- reactive protein) and ESR (erythrocyte sedimentation rate).
This longitudinal study was approved by the Research Committee of the Santos Metropolitan
University, and all individuals had access to the terms of consent. A total of 56
individuals with rheumatoid arthritis were assessed, and the investigators selected 12 women
with a mean age of 45.38 who had been diagnosed with rheumatoid arthritis (RA) and who also
had mild chronic periodontitis (PD). All of the patients were referred from the outpatient
specialty medicals service and the rheumatologist's specialty outpatient clinic of the
Metropolitan University of Santos diagnosed and evaluated individuals in the test group and
the control group. The control group was composed of individuals who initiated periodontal
treatment, did not have any systemic involvement, and had probing depth compatible with the
individuals in the test group. The criteria for participation in the study included not
having any dental procedure performed in the last six months, not having used antibiotic
medication in the last six months, except for the use of drugs that could alter salivary
flow (antidepressants, anxiolytics, antihistamines, and diuretics among others), not
smoking, and not wearing braces.
The main parameters for the diagnosis of RA include counting the number of painful joints
and the number of swollen joints, inflammatory activity (ESR and PCR), assessment of pain
intensity, and assessment of joint mobility and functional capacity. Before the start of
periodontal treatment, these tests were performed, and blood tests (ESR and PCR) were
requested and evaluated by the rheumatologist in charge. The healthy subjects (control
group) also underwent blood tests.
Upon completion of amamneses, periodontal clinical examinations were performed by a
previously trained and calibrated periodontist, and in the sample studied, 10% were examined
twice for each of the clinical criteria in order to obtain the intra-examiner reliability as
measured by Kappa statistics (0.87).
The investigators observed the clinical parameters of periodontal probing depth (PD) in six
points per tooth, and plaque index (PI) and gingival index (GI), conducted dichotomously for
cheeks, buccal, mesial, distal and lingual/ palatal. All of the participants received
radiographic, periapical, dental examinations in order to check the height level of the
cortical bone.
Subjects received oral hygiene devices and underwent therapy for full mouth disinfection,
and patients followed the protocol of holding two sessions with an interval of less than 24
hours between sessions. At the beginning of each session, oral hygiene instructions were
given to each subject individually and the investigators tried to teach patients the correct
way of using a brush and floss. The treatment was performed by scraping by a single
periodontist who was blinded to the participants and the data obtained in clinical trials.
Each participant received seven doses of the individually-based mouthwash chlorhexidine
0.12%, to be used within seven calendar days after execution of the first session of the
proposed therapy, and patients were told to always use it after brushing the last thing at
night and then to wait 30 minutes to receive the maximum effectiveness of the chlorhexidine.
After the procedures for dental scaling and root planing, 90 days passed before reassessment
and new periodontal clinical and laboratory (ESR and PCR) tests were performed. Then the
participants were referred to clinics operating in the college of Dentistry UNIMES as
needed.
After tabulating the clinical and laboratory data for the participants included in this
study, the data were subjected to statistical analysis. For this, the investigator used the
software SPSS 13.0 and 5.0 bioestat. In all analytical situations a significance level of
95% should be adopted (α ≤.05). For each cluster of analytical interest, the characteristic
distribution of the sample was tested and among the selected statistical tests being used
were the statistical tests ANOVA with two factors (factor "health condition" - healthy or
rheumatoid factor and "periodontal treatment" - Immediate evaluation or after periodontal
treatment) and the Tukey's test.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |